Noninvasive Evaluation of Liver Fibrosis in a Sample of Putative Inactive HBV Carriers in Rome, Italy.

Marco Delle Monache Alessio PetrelliAlessandra RossiRoberto CecereConcetta MirisolaGianfranco CostanzoChiara FranciaFederica CeriniAndrea CavaniLorenzo Nosotti

Published in: The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale (2021)

Analysis shows lower effectiveness of FS vs. TE in the assessment of putative inactive HBV carriers. Furthermore, using FibroScan® and HBV-DNA can identify "false" inactive carriers.

Keyphrases

liver fibrosis
hepatitis b virus
liver failure
randomized controlled trial
systematic review
single molecule
cell free
nucleic acid